48 ms·

MDMA successfully completed Phase III trials for PTSD: https://clinicaltrials.gov/ct2/show/NCT03537014 https://clinicaltrials.gov/ct2/show/NCT03537014 results h

MDMA successfully completed Phase III trials for PTSD: https://clinicaltrials.gov/ct2/show/NCT03537014 https://clinicaltrials.gov/ct2/show/NCT03537014 results here: https://www.pharmacytimes.com/view/phase-3-trial-of-mdma-therapy-for-ptsd-finds-excellent-results-safety-record https://www.pharmacytimes.com/view/phase-3-trial-of-mdma-the... Psilocybin can provide peace to terminally ill patients: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/ and it's in Phase II trials for major depressive disorder: https://clinicaltrials.gov/ct2/show/NCT03866174 https://clinicaltrials.gov/ct2/show/NCT03866174 and already has successful results in a small cohort, as published in JAMA Psychiatry: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2772630 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/... hell, ketamine is FDA approved for depression: https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified https://www.fda.gov/news-events/press-announcements/fda-appr...

DubiousPusher 5y ago
> MDMA successfully completed Phase III trials for PTSD: Cool. I look forward to seeing how it performs in long term practice. > Psilocybin can provide peace to terminally ill patients: Looks promising, though that is a single study with a small sample size. > and it's in Phase II trials for major depressive disorder: Again, compelling but small sample size > hell, ketamine is FDA approved for depression This approval is based on self reported symptom data from phase III trials and currently is backed up with any extrinsic measurements such as reduced suicide. It's not nothing but it's not a slam dunk yet. Again, it's all very preliminary though it looks promising. I don't see any evidence to suggest it will become the standard of care soon but it may in the future. We just have to wait and see.

DubiousPusher 5y ago

> MDMA successfully completed Phase III trials for PTSD: Cool. I look forward to seeing how it performs in long term practice. > Psilocybin can provide peace to terminally ill patients: Looks promising, though that is a single study with a small sample size. > and it's in Phase II trials for major depressive disorder: Again, compelling but small sample size > hell, ketamine is FDA approved for depression This approval is based on self reported symptom data from phase III trials and currently is backed up with any extrinsic measurements such as reduced suicide. It's not nothing but it's not a slam dunk yet. Again, it's all very preliminary though it looks promising. I don't see any evidence to suggest it will become the standard of care soon but it may in the future. We just have to wait and see.